Abstract: A compound, having a structure represented by a formula (I), and prepared by one pot synthesis of benzophenone hydrazone, 7-chloroisatin, and copper(II) acetate monohydrate, and refluxing in 100 mL of anhydrous methanol solvent for 48 hrs. A method for preparing the compound includes: collecting and placing 0.0235 g of benzophenone hydrazone, 0.6914 g of 7-chloroisatin, and 0.6720 g of copper(II) acetate monohydrate complex in a 100.0 mL flask; adding 50 mL of anhydrous methanol as a solvent; stirring a resulting mixture at room temperature for 48 hrs; performing column chromatography separation, and elution with petroleum ether/dichloromethane in a volume ratio of 1:1, and collecting final component points and naturally volatilizing the final component points to obtain 7(E)-chloro-3-diphenylmethylindolin-2-one crystals. The compound is used as a catalyst for reaction between benzophenone imine and trimethylsilonitrile, and has a catalytic effect with a conversion rate reaching 99%.

Abstract: A 5-bromoquinazoline derivative (I), structural formula thereof is as follows: the synthesis method thereof comprises weighing 1.18 g of 5-bromoisatin, 2.5503 g of ammonium formate and 100 ml of absolute methanol in a 250 mL round-bottom flask, heating, stirring and refluxing for 48 h, stopping reaction, rotating to obtain 1.6033 g of filter residue crude product, carrying out column chromatography separation by using dichloromethane and absolute methanol according to a volume ratio of 1:1, and obtaining a target crystal compound I; the application of the 5-bromoquinazoline derivative compound crystal (I), as a catalyst has a good catalytic effect in nitrile silicification reaction of benzaldehyde and auto-polymerization reaction of benzophenone hydrazone, the conversion rates thereof respectively reach 39% and 76%, and the crystal (I) can be used as an anti-cancer reagent which has certain anti-cancer activity of breast cancer, liver cancer and lung cancer.

Abstract: A method of synthesizing a 2-hydroxyphenyl-5-pyrimide ketone represented by the following chemical formula (I), including: weighing 0.048 g of a palladium complex, 0.8413 g of chromone-3-formaldehyde and 2.5719 g of ammonium formate into a 100 mL round bottom flask, then adding 50 mL of anhydrous methanol to dissolve, heating to reflux for 36 h, then stopping the reaction, performing column chromatography with petroleum ether and dichloromethane in a volume ratio of 1:1, and then naturally volatilizing the first component to obtain a light yellow crystal, namely the 2-hydroxyphenyl-5-pyrimidine ketone; wherein the chemical formula of the compound (I) is as follows: and an use of compound (I) as a catalyst in the reaction of benzophenone imine and trimethylsilyl nitrile showing a good catalytic performance, with a conversion rate of 69.1%.

Abstract: A 5-methoxyquinazoline derivative compound I, having a structure represented by formula I: A 5-methylquinazoline derivative compound II, having a structure represented by formula II A method for preparing crystals of a 5-methoxyquinazoline derivative compound I and a 5-methylquinazoline derivative compound I, includes: adding 0.8847 g of 5-methoxyisatin, 0.8256 g of 5-methylisatin, 2.6963 g of ammonium formate, and 100 mL of anhydrous methanol in a 250 mL round-bottomed flask; heating and stirring a resulting mixture for refluxing for 48 hrs, stopping reaction, and performing rotary filtration and obtaining a crude filter residue; and performing column chromatography on the crude filter residue using dichloromethane and anhydrous methanol at a volume ratio of 1:1, and respectively obtaining the crystal of 5-methoxyquinazoline derivative compound I and the crystal of 5-methylquinazoline derivative compound II.

Abstract: A tetracarbonyl cyclobutene dihydrate compound, having a chemical formula (I). A method of synthesizing the tetracarbonyl cyclobutene dihydrate compound, includes: a synthesis step, a separation step, and a purification step. The synthesis step includes: collecting and dissolving 0.5728 g of squaric acid, 2.7948 g of ammonium formate, and 0.0480 g of the palladium complex in 100 mL of anhydrous methanol, heating and stirring a resulting mixture to reflux for 48 hrs, and stopping the reaction. The separation step includes: performing column chromatography analysis on reaction products according to a volume ratio of dichloromethane to anhydrous methanol of 8:2, to obtain a target product. A method of using the tetracarbonyl cyclobutene dihydrate compound, includes: using tetracarbonyl cyclobutene dihydrate compound as a catalyst in addition reaction between ethyl pyruvate and nitromethane, where a conversion rate of ethyl pyruvate reaches 96.1%.

Abstract: A 5-methoxyquinazoline derivative compound I, having a structure represented by formula I: A 5-methylquinazoline derivative compound II, having a structure represented by formula II A method for preparing crystals of a 5-methoxyquinazoline derivative compound I and a 5-methylquinazoline derivative compound I, includes: adding 0.8847 g of 5-methoxyisatin, 0.8256 g of 5-methylisatin, 2.6963 g of ammonium formate, and 100 mL of anhydrous methanol in a 250 mL round-bottomed flask; heating and stirring a resulting mixture for refluxing for 48 hrs, stopping reaction, and performing rotrary filtration and obtaining a crude filter residue; and performing column chromatography on the crude filter residue using dichloromethane and anhydrous methanol at a volume ratio of 1:1, and respectively obtaining the crystal of 5-methoxyquinazoline derivative compound I and the crystal of 5-methylquinazoline derivative compound II.

Abstract: A tetracarbonyl cyclobutene dihydrate compound, having a chemical formula (1). A method of synthesizing the tetracarbonyl cyclobutene dihydrate compound, includes: a synthesis step, a separation step, and a purification step. The synthesis step includes: collecting and dissolving 0.5728 g of squaric acid, 2.7948 g of ammonium formate, and 0.0480 g of the palladium complex in 100 mL of anhydrous methanol, heating and stirring a resulting mixture to reflux for 48 hrs, and stopping the reaction. The separation step includes: performing column chromatography analysis on reaction products according to a volume ratio of dichloromethane to anhydrous methanol of 8:2, to obtain a target product. A method of using the tetracarbonyl cyclobutene dihydrate compound, includes: using tetracarbonyl cyclobutene dihydrate compound as a catalyst in addition reaction between ethyl pyruvate and nitromethane, where a conversion rate of ethyl pyruvate reaches 96.1%.

Abstract: A 5-bromoquinazoline derivative (I), structural formula thereof is as follows: the synthesis method thereof comprises weighing 1.18 g of 5-bromoisatin, 2.5503 g of ammonium formate and 100 ml of absolute methanol in a 250 mL round-bottom flask, heating, stirring and refluxing for 48 h, stopping reaction, rotating to obtain 1.6033 g of filter residue crude product, carrying out column chromatography separation by using dichloromethane and absolute methanol according to a volume ratio of 1:1, and obtaining a target crystal compound I; the application of the 5-bromoquinazoline derivative compound crystal (I), as a catalyst has a good catalytic effect in nitrile silicification reaction of benzaldehyde and auto-polymerization reaction of benzophenone hydrazone, the conversion rates thereof respectively reach 39% and 76%, and the crystal (I) can be used as an anti-cancer reagent which has certain anti-cancer activity of breast cancer, liver cancer and lung cancer.

Abstract: Disclosed is a sodium squarate hexahydrate complex of the structural formula (I). Its synthesis method includes the following steps. 0.6621 g of squaric acid, 2.6128 g of ammonium formate and 100 ml of anhydrous methanol are weighed and put into a 250 mL round-bottom flask, and heated and stirred to reflux for 48 h, then the reaction is stopped, subsequently the flask is added with 10 mL of a 1M HCl solution, and extracted with 3×15 mL of dichloromethane, and then a combined extraction solution is washed again with 15 mL of a 12M NaOH solution, and extracted again with 3×15 mL of dichloromethane. The extraction solution is subjected to rotary evaporation and separation through column chromatography to obtain a crystal complex; the use of this sodium squarate hexahydrate complex (I) is to use the sodium squarate hexahydrate complex (I) as a catalyst.

Abstract: Disclosed is a method of synthesizing a 2-hydroxyphenyl-5-pyrazinel ketone represented by the following chemical formula (I), comprising: weighing 0.048 g of a palladium complex, 0.8413 g of chromone-3-formaldehyde and 2.5719 g of ammonium formate into a 100 mL round bottom flask, then adding 50 mL of anhydrous methanol to dissolve, heating to reflux for 36 h, then stopping the reaction, performing column chromatography with petroleum ether and dichloromethane in a volume ratio of 1:1, and then naturally volatilizing the first component to obtain a light yellow crystal, namely the 2-hydroxyphenyl-5-pyrazinel ketone, referred to as compound (I); the chemical formula of the compound (I) is as follows: an application of compound (I) as a catalyst in the reaction of benzophenone imine and trimethylsilyl nitrile showing a good catalytic performance, with a conversion rate of 69.1%.

Abstract: A chiral platinum complex having a chemical formula (I): A method for synthesizing the chiral platinum complex (I), includes: dissolving 0.700 g of Pt(DMSO)2(NO3)2 in 30 mL of dichloromethane as a solvent to yield a solution; adding 0.450 g of 1,4-(4R)-diphenyl-2-oxazolinyl benzene to the solution, and reflux a resulting mixture for reaction for 48 hrs, and stopping the reaction; filtrating reaction products; and adding dichloromethane and petroleum ether, and naturally volatilizing to yield a binuclear platinum complex single crystal. A method for condensation of benzophenone imine and trimethylsilitrile by using the chiral platinum complex as a catalyst. A method for treating cancer includes administering the chiral platinum complex to a patient in need thereof. The cancer includes: lung cancer (A549), nasopharyngeal carcinoma (KB), anti-drug-resistant nasopharyngeal carcinoma (KB-VIn), and human breast cancer (MCF-7).

Abstract: A chiral platinum complex having a chemical formula (I): A method for synthesizing the chiral platinum complex (I), includes: dissolving 0.700 g of Pt(DMSO)2(NO3)2 in 30 mL of dichloromethane as a solvent to yield a solution; adding 0.450 g of 1,4-(4R)-diphenyl-2-oxazolinyl benzene to the solution, and reflux a resulting mixture for reaction for 48 hrs, and stopping the reaction; filtrating reaction products; and adding dichloromethane and petroleum ether, and naturally volatilizing to yield a binuclear platinum complex single crystal. A method for condensation of benzophenone imine and trimethylsilitrile by using the chiral platinum complex as a catalyst. A method for treating cancer includes administering the chiral platinum complex to a patient in need thereof. The cancer includes: lung cancer (A549), nasopharyngeal carcinoma (KB), anti-drug-resistant nasopharyngeal carcinoma (KB-VIn), and human breast cancer (MCF-7).

Abstract: A laminar structure of semiconductors comprises a silicon substrate, an epitaxial layer, a protective layer, a first layer and a second layer. The epitaxial layer is arranged above the silicon substrate and the protective layer is arranged below the silicon substrate. Thermal expansion coefficients of the epitaxial layer and the protective layer are both either greater than or less than that of the silicon substrate. The first layer is arranged between the silicon substrate and the protective layer; and the second layer is arranged between the silicon substrate and the epitaxial layer, wherein the band gap of the first layer and the second layer are both greater than 3 eV. By arranging the protective layer below the silicon substrate, stress generated between the silicon substrate and the epitaxial layer can be reduced to prevent occurrence of bending or crack. Therefore, yield can be promoted and costs can be reduced.

Abstract: A laminar structure of semiconductors comprises a substrate, an epitaxial layer, a protective layer, a first layer and a second layer. The epitaxial layer is arranged above the substrate and the protective layer is arranged below the substrate. Thermal expansion coefficients of the epitaxial layer and the protective layer are simultaneously greater than or less than that of the substrate. The first layer is arranged between the substrate and the protective layer; and the second layer is arranged between the substrate and the epitaxial layer, wherein the band gap of the first layer and the second layer are both greater than 3 eV. By a protective layer arranged below the substrate, stress generated between the substrate and the epitaxial layer can be reduced to prevent occurrence of bending or crack. Therefore, yield can be promoted and costs can be reduced. A manufacturing method thereof is also herein provided.

Abstract: Among other things, the present invention addresses timing issues related to a polarity control scheme in DFE implementation. Multiplexing that may be necessary for implementing a polarity control scheme is incorporated into multiplexing that may be required to convert half rate data into full rate data in a delay element of a DFE. Clocking signals are provided to a multiplexer that are encoded with polarity information. The various clock signals are generated using a clock generation circuit that incorporates polarity control.

Abstract: An integrated circuit includes a duty cycle detection circuit, a comparator circuit, and a tuning circuit. The duty cycle detection circuit receives a clock signal, such as a system clock signal, and detects the level of duty cycle distortion in the clock signal. The comparator circuit then generates an output based on the level of duty cycle distortion that is detected in the clock signal. The tuning circuit may accordingly adjust the clock signal based on the output generated by the comparator circuit to produce an adjusted clock output signal. As an example, the clock output signal produced by the tuning circuit after the adjustment may have a 50% (or significantly close to 50%) duty cycle.

Abstract: In an embodiment of the present invention, a feedback technique is used to track a reference signal with a DFE summing node common mode voltage. For example, in an embodiment implemented in CML, the feedback signal shifts both differential signals (e.g., the summing node common voltage and the reference voltage) by the same amount. In such an embodiment, the feedback technique preferably changes the reference common mode but not its differential mode.

Abstract: A circuit includes a receiver circuit, a decision feedback equalizer circuit, and a control loop circuit. The receiver circuit receives a data signal and generates an input signal in response to the data signal. The decision feedback equalizer circuit includes a tap driver and a first current source coupled to the tap driver. The tap driver drives the input signal based on a tap weight. The control loop circuit varies a current through the first current source based on variations in the input signal to reduce changes in the tap weight that are caused by the variations in the input signal.